Skip to content

Upstream Bio, Inc. UPB Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
Theravance Biopharma logo
Theravance BiopharmaTBPH
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s operating lease right-of-use assets in other assets?
Upstream Bio, Inc. (UPB) reported operating lease right-of-use assets in other assets of $1.07M in Q1 2026.
How has Upstream Bio, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
Upstream Bio, Inc.'s operating lease right-of-use assets in other assets decreased by 35.1% year-over-year, from $1.65M to $1.07M.
What is the long-term trend for Upstream Bio, Inc.'s operating lease right-of-use assets in other assets?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s operating lease right-of-use assets in other assets has grown at a 433.1% compound annual growth rate (CAGR), from $43K to $1.22M.